GameStop Corp. vs Immunovant Inc. Common Stock — how do they compare? GameStop Corp. trades at $25.37 (market cap $12.75B), while Immunovant Inc. Common Stock trades at $30.25 (market cap $6.25B). The key difference: GameStop Corp. is far larger — about 2× Immunovant Inc. Common Stock's market cap, and GameStop Corp. is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GameStop Corp. for 61 Days and Immunovant Inc. Common Stock for 0 Days on average.
| GME | IMVT | |
|---|---|---|
Market Cap | $12.75B | $6.25B |
Volume | 13,026,993 | 1,755,411 |
Sector | Consumer Cyclical | Health |
52-Week High | $26.53 | $44.96 |
52-Week Low | $17.87 | $17.03 |
Typical Hold Time | 61 Days | 0 Days |
Enterprise Value | $12.03B | $5.35B |
Signals from Pluang's Aura AI — not financial advice
GME trades at $24.58, down 0.73% on the day, with a bullish technical signal from moving averages and strong insider buying. Revenue declined to $3.82B in 2025, but net income improved to $131.3M with a 25.16% net margin. Recent news highlights CEO Ryan Cohen's aggressive share purchases, fueling positive sentiment.
Outlook hinges on execution of the high-margin collectibles pivot and eBay acquisition potential. Risks include revenue volatility and competitive pressures. Analysts are cautious with 55.55% hold ratings, but insider confidence offers a bullish counter-narrative.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Global Market Group Ltd. operates an Internet website that connects Chinese manufacturers with international buyers. The Company's customers can post company profiles and product information in standardized formats; post product listings; and trade leads.
Read more on GME →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →